192
Participants
Start Date
July 2, 2009
Primary Completion Date
April 1, 2013
Study Completion Date
April 1, 2013
Chloroquine
The current gold standard for radical cure of P. vivax malaria in many areas of the world is chloroquine (CQ); typically 600 mg day 1, 600 mg day 2, 300 mg day 3 for clearance of the acute parasitemia. After this Tafenoquine will be given and subject will be followed up.
Primaquine
Primaquine (PQ) is another 8 aminoquinoline drug available for Malaria treatment
Tafenoquine
Once daily on Day 1 only. For Part B and C of this study Chloroquine will be given to treat Malaria
GSK Investigational Site, Bangkok
GSK Investigational Site, Tak
Lead Sponsor
Medicines for Malaria Venture
OTHER
GlaxoSmithKline
INDUSTRY